Barbara Simon, MD: Advances in Insulin for Diabetic Patients


There are now more insulin options for patients with diabetes than ever before.

There are more options of insulin for diabetic patients than ever.

With many different formulations of insulin available, many advocates have honed in on cost as a key barrier preventing better care for patients with diabetes.

Recently, during HCPLive’s® State of the Science event called New Advances in Insulin Therapy for the Management of Type 2 Diabetes a panel of experts spoke about new and emerging treatment for diabetes and what challenges still remain in care.

In an interview with HCPLive, Barbara Simon, MD, associate professor of endocrinology, Sidney Kimmel Medical Center at Thomas Jefferson University discussed the panel and gave an overview on the current state of diabetes care.

Related Videos
Alexandra Louise Møller, MS, PhD | Credit: LinkedIn
A panel of 5 experts on Cushing's syndrome
A panel of 5 experts on Cushing's syndrome
Optimizing Diabetes Therapies with New Classifications
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Should We Reclassify Diabetes Subtypes?
What Should the American Academy of Physician Associates Focus on in 2025?
GLP-1 Agonist Safety Risks and Obesity Stigma with Kevin Peterson, MD, MPH
Video 8 - "Pathophysiology of Hypercortisolism"
Video 7 - "Evolving Perception of Autonomous Adrenal Hypercortisolism "
© 2024 MJH Life Sciences

All rights reserved.